Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SLC2A3 |
| Upstream (Parents) |
|---|
| (<<) IL6 → SLC2A3 |
| (<<) ADM → SLC2A3 |
| (<<) AP1M2 → SLC2A3 |
| (<<) DAGLB → SLC2A3 |
| (<<) SPINT1 → SLC2A3 |
| (<<) DOPEY2 → SLC2A3 |
| (<<) SLC2A14///SLC2A3 → SLC2A3 |
| Downstream (Children) |
|---|
| SLC2A3 → IL6 (>>) |
| SLC2A3 → AP1M2 (>>) |
| SLC2A3 → IGFBP3 (>>) |
| SLC2A3 → SOCS3 (>>) |
| SLC2A3 → NR4A3 (>>) |
| SLC2A3 → CTAG2 (>>) |
| SLC2A3 → SLC2A14///SLC2A3 (>>) |
| SLC2A3 → SLC4A4 (>>) |
